Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 2
2005 2
2006 1
2007 1
2008 2
2009 3
2010 12
2011 9
2012 16
2013 14
2014 15
2015 19
2016 12
2017 8
2018 6
2019 3
2020 2
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087).
Haigentz M Jr, Lee JY, Chiao EY, Aboulafia DM, Ratner L, Ambinder RF, Baiocchi RA, Mitsuyasu RT, Wachsman W, Sparano JA, Rudek MA. Haigentz M Jr, et al. Clin Cancer Res. 2023 Dec 15;29(24):5038-5046. doi: 10.1158/1078-0432.CCR-23-1142. Clin Cancer Res. 2023. PMID: 37523145 Clinical Trial.
Locally Advanced Lung Cancer.
Oh S, Botros GN, Patel M, Haigentz M, Patel E, Kontopidis I, Langenfeld J, Deek MP, Jabbour SK. Oh S, et al. Among authors: haigentz m. Hematol Oncol Clin North Am. 2023 Jun;37(3):533-555. doi: 10.1016/j.hoc.2023.02.007. Epub 2023 Apr 4. Hematol Oncol Clin North Am. 2023. PMID: 37024391 Review.
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus-Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.
Aggarwal C, Saba NF, Algazi A, Sukari A, Seiwert TY, Haigentz M, Porosnicu M, Bonomi M, Boyer J, Esser MT, Cheng LI, Agrawal S, Jennings EC, Durham NM, Fraser K, Lissa D, Gong M, Ceaicovscaia N, Gascó Hernández A, Kumar R. Aggarwal C, et al. Among authors: haigentz m. Clin Cancer Res. 2023 Feb 1;29(3):560-570. doi: 10.1158/1078-0432.CCR-22-1987. Clin Cancer Res. 2023. PMID: 36455147 Free PMC article.
Exhaled breath analysis in the diagnosis of head and neck cancer.
Mäkitie AA, Almangush A, Youssef O, Metsälä M, Silén S, Nixon IJ, Haigentz M Jr, Rodrigo JP, Saba NF, Vander Poorten V, Ferlito A. Mäkitie AA, et al. Among authors: haigentz m jr. Head Neck. 2020 Apr;42(4):787-793. doi: 10.1002/hed.26043. Epub 2019 Dec 19. Head Neck. 2020. PMID: 31854494 Review.
Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer.
Argiris A, Li S, Savvides P, Ohr JP, Gilbert J, Levine MA, Chakravarti A, Haigentz M Jr, Saba NF, Ikpeazu CV, Schneider CJ, Pinto HA, Forastiere AA, Burtness B. Argiris A, et al. Among authors: haigentz m jr. J Clin Oncol. 2019 Dec 1;37(34):3266-3274. doi: 10.1200/JCO.19.00555. Epub 2019 Oct 16. J Clin Oncol. 2019. PMID: 31618129 Free PMC article. Clinical Trial.
99 results